 
1-10 of 200 for Drug Zyprexa
Read about efficacy, safety, and formulations of ZYPREXA, and find resources to help ... Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%,
Currently, no single agent has been approved for marketing by the U.S. Food and Drug Administration as monotherapy to treat all stages of bipolar disorder. ... Related Link: Zyprexa, Eli Lilly and Co.
The drug, olanzapine (trade name Zyprexa), belongs to a relatively new family of medications called atypical antipsychotics, which are used to treat schizophrenia, paranoia and manic...
Describes the medication olanzapine (Zyprexa), a drug used for treating patients with schizophrenia and manic episodes associated with bipolar I disorder. ... BRAND NAME: Zyprexa, Zydis ... DRUG CLASS AND MECHANISM:
Zyprexa was approved by the federal Food and Drug Administration in 1996 for treatment of schizophrenia and later for bi-polar disorder.
- Mississippi filed a lawsuit Monday against Eli Lilly and Co., alleging improper sales and marketing of the anti-psychotic prescription drug Zyprexa.
Blumenthal Sues Eli Lilly For Illegally Marketing Antipsychotic Drug Zyprexa For Unapproved Uses Abstract: Attorney General Richard Blumenthal today sued Eli Lilly and Company, Inc. ... March 11, 2008
The United States Attorney's Office ... Eastern District of Pennsylvania ... USAO Home Page
David Beshara, chief pharmacy officer for Tennessee's Medicaid program, said that his state declined Lilly's offer to implement the program in exchange for placing Zyprexa on its preferred-drug list.
Jan. 31 (Bloomberg) -- Eli Lilly & Co. said it received a subpoena in November from a U.S. grand jury in Pennsylvania seeking documents related to the marketing of the company's best- selling drug,
|
   |